Similar to IL-1β, extracellular IL-33 activates intracellular signaling pathways via binding to ST2, a cell surface receptor [29], while in KCs, ST2 expression is stimulated by ultraviolet B (UVB) rays [25–28]. Here, IL33 is linked to dry eye syndrome.